Results 41 to 50 of about 5,741 (187)
The role of vitamin D in menopausal women’s health
Frontiers in Physiology, 2023 Vitamin D (VD) is known to play an important role in the maintenance of calcium homeostasis and bone metabolism. In recent years, there has also been a growing interest in Vitamin D for health issues beyond the bones.
Zhaojun Mei, Hong Hu, Yi Zou, Dandan Li
doaj +1 more source
Differentiated approach to the treatment of genitourinary syndrome in perimenopausal women
Репродуктивная эндокринология, 2019 Objective. To compare the clinical efficacy of monotherapy with menopausal hormonal therapy (climonorm) in the treatment of genitourinary syndrome of menopause with the effectiveness of monotherapy by M-anticholinergic mirabegron (betmiga) and a ...
Ю. П. Вдовиченко +3 more
doaj +1 more source
Manifestations of somatic disturbances in early postmenopause in women after physiological and surgical menopause [PDF]
Vojnosanitetski Pregled, 2006 Background/Aim. The most common secondary manifestations of menopause are clinical manifestations of estrogen deficiency. They could be early and late. The aim of this study was to compare manifestations of somatic disturbances in early postmenopause in ...
Ninčić Dejan +3 more
doaj +1 more source
Ovarian preservation techniques for female pelvic radiotherapy techniques: a critical review [PDF]
, 2016 IntroductionAdvances in treatment over recent years have increased the long-term survival of young, female cancer patients; unfortunately these treatments bring a significant risk of ovarian failure and infertility.
Bridge, P, Durrant, A
core +1 more source
Hormone therapy for genitourinary syndrome of menopause: reality and prospects
Клинический разбор в общей медицинеGenitourinary syndrome of menopause still represents one of the most pressing unresolved issues of modern gynecology. High prevalence and the data suggesting a marked decline in the quality of life in general and sexual life in particular in patients of ...
Mekan R. Orazov +2 more
doaj +1 more source
Ospemifene May Not Treat Vulvar Atrophy: A Report of Two Cases
Sexual Medicine, 2016 Introduction: Ospemifene (Osphena, Shionogi Inc, Florham, NJ, USA) is an estrogen agonist and antagonist approved by the U.S. Federal Drug Administration for the treatment of “moderate to severe dyspareunia, a symptom of vulvar and vaginal atrophy, due ...
Andrew T. Goldstein, MD +1 more
doaj +1 more source
BMC Women's Health, 2021 Objective To study knowledge regarding genitourinary syndrome of menopause (GSM) and the treatments for it and to analyze treatment adherence during the COVID-19 confinement.
Laura Baquedano Mainar +5 more
doaj +1 more source
Treatment of Female Sexual Dysfunction Due to Dyspareunia with Solid-State Vaginal Laser and Recombinant Platelet-Derived Epidermal Growth Factors A Viable Possibility? [PDF]
, 2023 Objective: To examine the efficacy and safety of non-pharmacological and non-ablative options (or a combination of these) for postmenopausal dyspareunia.
MENDOZA, NICOLAS, Quereda, Francisco
core +1 more source
Quality in SportDyspareunia, defined as pain during or immediately after sexual intercourse, is one of the most common and troublesome symptoms of Genitourinary syndrome of menopause (GSM), affecting a significant number of perimenopausal and postmenopausal women. This
Julia Dąbrowska +9 more
doaj +1 more source